AbbVie ABBV Earnings Call Transcripts

NYSE ABBV
$288.61 +2.62 (+0.91%)
As of: Oct 29, 2026 · 2:30 PM EDT
26 earnings calls on file for AbbVie, from Q4 2019 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

AbbVie Q2 2026 Earnings Call

Jul 31, 2026 9,539 words · 41 min read
  • Elizabeth SheaSenior Vice President, Investor Relations
  • Robert A. MichaelChairman and Chief Executive Officer
  • Jeffrey Ryan StewartExecutive Vice President, Chief Commercial Officer
  • Roopal ThakkarExecutive Vice President, Research and Development, Chief Scientific Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

AbbVie Earnings Call Transcripts

Calls26
LatestJul 31, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2024

Fiscal 2023

Fiscal 2022

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 26 AbbVie transcripts Register to get access to AbbVie’s earnings call transcripts.